✨ Unlock Data Exports And Disclosure Access. Start Your 30-Day Free Trial Today →

Amicus Therapeutics Inc

Common Name
Amicus Therapeutics
Country
United States
Sector
Healthcare
Industry
Biotechnology
Employees
499
Ticker
FOLD
Exchange
NASDAQ/NMS
Description
Amicus Therapeutics Inc. is a biopharmaceutical company dedicated to developing advanced therapies for rare and orphan diseases. Its primary focus is on genetic disorders, particularly lysosomal stora...

Disclosures of Amicus Therapeutics

Explore Amicus Therapeutics's complete collection of publicly available corporate disclosures, including annual reports, sustainability reports, financial statements, ESG data spreadsheets, and related web publications. Each document is sourced directly from Amicus Therapeutics's official channels and fully traceable to its official company sources.

The table below lists all of Amicus Therapeutics's' corporate disclosure by name and reporting period, ensuring full transparency and easy access.

If you want to search across Amicus Therapeutics's' disclosures for specific data or insights, use our Disclosure Search.

NameReporting Period
Financial & Extra-Financial Disclosure
2024
10-K
2024
ESG Report
2024
10-K
2023
ESG Report
2023
Financial & Extra-Financial Disclosure
2023
Annual Report
2023
10-K
2022
ESG Report
2022
10-K
2021
ESG Report
2021
Financial Report
2021
ESG Data Spreadsheet
2021
10-K
2020
Financial Report
2020
ESG Data Spreadsheet
2020
10-K
2019
Financial Report
2019
10-K
2018
ESG Data Spreadsheet
2018
10-K
2017
ESG Data Spreadsheet
2017
10-K
2016
ESG Data Spreadsheet
2016
10-K
2015
10-K
2014
10-K
2013
10-K
2012
10-K
2011
10-K
2010
10-K
2009
Real-Time Disclosures Datafeed

Get Notified Within Seconds of New Corporate Disclosures

Tracenable is building a high-speed disclosure monitoring system that delivers instant alerts when companies publish new reports or data. Could a real-time datafeed (via SFTP, RSS or API) enhance your investment or analytical workflows?